Forschungs- & Entwicklungsinformationsdienst der Gemeinschaft - CORDIS

FP5

ANTICANCER RETINOIDS Berichtzusammenfassung

Project ID: QLK3-CT-2002-02029
Gefördert unter: FP5-LIFE QUALITY
Land: Italy

Novel Acute Myelogenous Leukemia (ALM) treatment paradigm

HDAC inhibitors (HDACi's) induce expression of the death ligand TRAIL and this molecular event is responsible for apoptosis in acute myeloid leukaemia systems after epigenetic treatment.

This has been the first time in which TRAIL is specifically linked to HDACi's and explains the previously noted tumour-selective action of some HDACi's.

We:
- showed that TRAIL-induction causes HDACi-induced apoptosis,
- described the corresponding mechanisms,
- separated the effects of HDACi action on inhibition of cell cycle progression, differentiation and apoptosis, and
- demonstrated TRAIL induction in AML patient's blasts.

Kontakt

Lucia LUCIA ALTUCCI, (Assistant Professor)
Tel.: +39-081-5667569
Fax: +39-081-450169
E-Mail-Adresse
Folgen Sie uns auf: RSS Facebook Twitter YouTube Verwaltet vom Amt für Veröffentlichungen der EU Nach oben